Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor-Reference-Cited by-同舟云学术

Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor

Published:2024-07 Issue:7 Volume:36 Page:1534-1549.e7
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Regmi Ajit,Aihara Eitaro,Christe Michael E.,Varga Gabor,Beyer Thomas P.,Ruan Xiaoping,Beebe Emily,O’Farrell Libbey S.,Bellinger Melissa A.,Austin Aaron K.,Lin Yanzhu,Hu Haitao,Konkol Debra L.,Wojnicki Samantha,Holland Adrienne K.,Friedrich Jessica L.,Brown Robert A.,Estelle Amanda S.,Badger Hannah S.,Gaidosh Gabriel S.,Kooijman Sander,Rensen Patrick C.N.,Coskun Tamer,Thomas Melissa K.,Roell William^ORCID

Funder

Leids Universitair Medisch Centrum

Eli Lilly and Company

Publisher

Elsevier BV

Reference62 articles.

1. IDF Diabetes Atlas,2021

2. Efficacy and safety of LY3298176, a novel dual gip and glp-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial;Frias;Lancet,2018

3. The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes;Wilson;Diabetes Obes. Metab.,2020

4. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes;Frías;N. Engl. J. Med.,2021

5. Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial;Heise;Lancet Diabetes Endocrinol.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tirzepatide’s innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health;Frontiers in Pharmacology;2024-08-28

2. New insights into the regulation of GIPR signalling;Nature Reviews Endocrinology;2024-08-22

3. The unexpected role of GIP in transforming obesity treatment;Trends in Endocrinology & Metabolism;2024-08